Clinical Trials Logo

Integrative Medicine clinical trials

View clinical trials related to Integrative Medicine.

Filter by:
  • None
  • Page 1

NCT ID: NCT05833165 Recruiting - Cancer Clinical Trials

Feasibility of Integrating Homeopathic Approach in a Comprehensive Cancer Center

Start date: January 1, 2023
Phase:
Study type: Observational

Supportive and palliative care play an important role in cancer treatment, and when introduced early can improve quality of life and may even increase median survival rates, as shown in patients with advanced lung cancer. Complementary and integrative medicine (CIM) is a popular supportive approach among oncology patients and is on the rise worldwide. In many countries, homeopathy is being one the CIM methods integrated with a general sense that this treatment is beneficial to the well-being and quality of life (QoL) of cancer patients. In this observational study we will evaluate the feasibility of integrating homeopathic approach in patients attending the complementary and integrative oncology service at the division of oncology in Rambam Health Campus in Haifa, Israel, a major referral comprehensive cancer center. This observational study will evaluate three main ingredients of acceptance: - Obtaining the reasons that patients willing to integrate this supportive approach - Patient acceptance of this supportive approach as well as compliance with the homeopathic approach - Obtaining retrospective subjective information from the patients through validated quality of life questionnaires. (MYCaW, Distress Thermometer, and ESAS-R) Measures which are used routinely in integrative oncology encounters.

NCT ID: NCT05141097 Not yet recruiting - Clinical trials for Integrative Medicine

Integrative Medicine Quality of Life Study

Start date: December 1, 2021
Phase: Early Phase 1
Study type: Interventional

Integrative Medicine is an approach to health that addresses a person's mental, physical, social, spiritual, and environmental factors. Chronic diseases are best treated if the root cause is addressed, improving one's overall health. Health is defined by the WHO as "a state of complete physical, mental and social wellbeing, and not merely the absence of disease or infirmity." Many national institutions, such as the American Heart Association, American College of Cardiology, American Diabetes Association, and more, all affirm that lifestyle modifications are the number one treatment and prevention for the most common disorders: high blood pressure, obesity, diabetes, high cholesterol, etc. The generic term "lifestyle modifications" encompasses many aspects that can be impacted by Integrative Medicine. Patients present to be treated by Integrative Medicine practitioners frequently, and we would like to see how their quality of life is improving by being treated by this practice approach.

NCT ID: NCT04905927 Completed - Clinical trials for Failed Back Surgery Syndrome

Long Term Follow up of Failed Back Surgery Syndrome(FBSS)

Start date: June 14, 2021
Phase:
Study type: Observational

The purpose of this study is to reveal the effectiveness and satisfaction of integrative Korean medicine for Failed Back Surgery Syndrome(FBSS) by observation patients treated with integrative Korean medicine. This study is a prospective observational study. The subjects for study are patients diagnosed with Failed Back Surgery Syndrome(FBSS) and who have been admitted to Gangnam Jaseng Hospital of Korean medicine and Bucheon Jaseng Hospital of Korean medicine for 2011.11-2014.09. Medical records of selected patients will be analyzed, and telephone surveys will be conducted for each patient. The survey questions are Numeric rating scale (NRS), Oswestry disability index (ODI), quality of life, and Patient Global Impression of Change (PGIC), etc.

NCT ID: NCT04692597 Recruiting - Osteoarthritis Clinical Trials

Low Level Laser Therapy (LLLT) for the Treatment of Hand Osteoarthritis.

Start date: March 2, 2021
Phase: N/A
Study type: Interventional

This study is a randomized, control trial of Active Duty and DoD Beneficiaries, age 18 years or older, with complaints of hand osteoarthritis. Subjects will be randomized into one of two groups receiving either LLLT or sham LLLT. Subjects will receive LLLT or sham LLLT weekly over a period of six weeks. At each visit, patients will rate their pain using the Defense and Veterans Pain Rating Scale (DVPRS) and assess their functionality using the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire. Subjects will have a follow up visit six weeks after the treatment protocol for a final assessment of pain and function. The Phoenix Thera-Lase laser is a Class II, 510k cleared device (#K151521) and is legally marketed in the US. Investigators are using in accordance with its approved labeling and no changes to the approved labeling are being sought.

NCT ID: NCT03140345 Recruiting - Renal Dialysis Clinical Trials

Integrative HD Vascular Access Assessment

Start date: June 7, 2017
Phase: N/A
Study type: Observational

The aim of this two-year study is to explore the relationship among function of HVA, nail-fold capillaries and TCM constitutions based on hybridizing data mining techniques. This study will not only improve our understanding on the expressions of function of HVA, nailfold capillaries and tendency of TCM patterns, but also demonstrate the fundamental knowledge of a novel healthcare model on hemodialysis vascular access.

NCT ID: NCT02906423 Completed - Palliative Care Clinical Trials

Results From a Health System-wide Implementation of a Quality of Life Questionnaire

Start date: July 2012
Phase: N/A
Study type: Observational

The purpose of this retrospective chart review pilot study is to research the results and scores of the QOL questionnaire implemented across Allina Health clinics. This study will investigate average QOL scores by clinical population and demographic group, the change in scores over time, and the effect of clinical interventions on QOL scores. The results will provide insight into QOL trends within different patient populations and provide guidance regarding optimal treatment plans so that Allina caregivers can positively impact patients' QOL.